Tyrosur Gel 1 mg/g, 25 g in tubes
Ingredients
Active ingredient: tyrotricin,
1 g of gel contains 1 mg of tyrotricin;
inactive ingredients: cetylpyridinium chloride, propylene glycol, 96% ethanol, carbomer, trometamol, purified water.
Dosage Form
Gel.
Main physical and chemical properties: colorless, opalescent, viscous gel.
Pharmacotherapeutic group
Antibiotics for topical use.
ATC code D06A X08.
Pharmacological properties
Pharmacodynamics.
Tyrothricin is a mixture of various cyclic and linear polypeptides that exhibit antibacterial activity and is produced as an endotoxin by the anaerobic, spore-forming bacterium Bacillus brevis. This compound contains up to 70–80% tyrocidins (major cyclic decapeptides) and up to 20–30% gramicidins (neutral linear pentadecapeptides).
It is active primarily against Gram-positive bacteria such as Staph. aureus MSSA, Staph. aureus MRSA, Staph. Haemolyticus, Strep. pyogenes, Streptococcus viridans, Enterococcus faecalis, Diplococcus pneumoniae, Corynebacterium spp., *Neisseria meningitidis*, certain strains of *Neisseria gonorrhoeae*, fungi, and *Trichomonas*, as well as some Gram-negative bacteria and certain fungal species, including *Candida*.
Tyrothricin exerts a dose-dependent bacteriostatic or bactericidal effect against microorganisms such as Clostridia.
The release of substances such as nitrogen and phosphates from bacterial cells ensures the effectiveness of tyrocidin. Similar to cationic detergents, tyrocidin disrupts the osmotic barrier of bacterial cell membranes. Due to its direct effect on the bacterial cell wall, the drug’s action is not limited to inhibiting cell growth or division; it also accounts for tyrocidin’s bactericidal effect.
In addition, gramicidins form cation channels in the bacterial cell membrane, leading to potassium loss and, consequently, to a change in intracellular cation concentration and cytolysis. A component such as gramicidin subsequently disrupts phosphorylation processes in the respiratory chain.
Due to tyrotricin’s unique mechanism of action—which is not observed in systemic antibiotics—cross-resistance does not occur.
Tyrosur Gel accelerates the wound healing process by cleansing the wound bed and stimulating granulation and epithelialization.
Pharmacokinetics.
It is unknown to what extent tyrothricin is systemically absorbed. High concentrations have been detected in the stratum corneum (after application to intact skin) and directly within the wound.
Indications
Topical treatment of superficial wounds with minimal exudate and the presence of superinfection caused by pathogens sensitive to tyrothricin, such as lacerations, scratches, and abrasions.
Contraindications
Hypersensitivity to any component of the product.
Contraindicated for intranasal use; there are reports that this method of application may lead to a loss of smell.
Interactions with Other Medications and Other Types of Interactions
Unknown.
Special Precautions
Caution should be exercised when applying the product to the areas around the eyes, as this may cause a burning sensation.
Tyrosur Gel contains propylene glycol, which may cause skin irritation.
Use during pregnancy or breastfeeding.
There are no data on the effects of Tyrosur Gel during pregnancy. Adequate studies on the effects of tyrotricin and cetylpyridinium chloride on reproductive function in animals have not been conducted. The potential risk to humans is unknown; therefore, Tyrosur Gel should not be used during pregnancy.
It is unknown whether tyrotricin or cetylpyridinium chloride passes into breast milk; therefore, the product should not be used while breastfeeding.
Effect on the ability to drive or operate machinery.
No effect.
Directions for Use and Dosage
Apply a thin layer of the gel 2–3 times daily to the affected areas of the skin. For minor wounds and skin inflammation on exposed areas of the body, it is usually not necessary to cover them. For large lesions or weeping wounds, a protective bandage is recommended, which should be changed every 1–2 days.
The duration of treatment is determined on an individual basis, depending on the course of the disease. If no improvement is observed after one week of use, the treatment should be reviewed.
Children.
If necessary, Tyrosur gel may be used in children of any age.
Overdose
No cases of overdose have been reported.
Side Effects
Skin irritation, a burning sensation, allergic reactions, including erythema, hives, and contact dermatitis.
Shelf Life
3 years.
Do not use after the expiration date printed on the package.
Shelf life after first opening the tube: 3 months.
Storage conditions
Store at a temperature not exceeding 25 °C, out of reach of children.
Packaging
5 g or 25 g of gel per tube; 1 tube per cardboard box.
Dispensing category
Over-the-counter.
Manufacturer
Engelhard Arzneimittel GmbH & Co. KG/
Engelhard Arzneimittel GmbH & Co. KG.
Manufacturer’s location and address of its place of business.
Herzbergstrasse 3, 61138 Niederdorfelden, Germany/
Herzbergstraße 3, 61138 Niederdorfelden, Germany.
Similar products
Products from the same category











